Results 101 to 110 of about 376,982 (341)

Artifactual Prolongation of the Activated Partial Thromboplastin Time Associated With Hemoconcentration in Dogs [PDF]

, 1995
Susan R. O'Brien, Teresa S. Sellers, Dennis J. Meyer   +2 more
openalex   +1 more source

Acute hepatitis and haemolysis associated with doxycycline and rifampin administration in two weanling foals

Equine Veterinary Education, EarlyView.
Summary Two foals were being treated with a combination of oral doxycycline and rifampin for presumed Rhodococcus equi infections. After 3–4 weeks of antimicrobial administration, both foals presented with icterus and nonspecific clinical signs, including lethargy and inappetence.
A. Murdock, D. Wong, T. Hall, B. Sponseller, J. Howard, K. Frerichs, A. Bianco, R. Ruby   +7 more
wiley   +1 more source

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease [PDF]

, 1999
Jonas Oldgren
openalex   +1 more source

Integration of machine learning and viscoelastic testing to improve survival prediction in horses experiencing acute abdominal pain at a veterinary teaching hospital

Equine Veterinary Journal, EarlyView.
Abstract Background Viscoelastic coagulation testing (VCT) identifies subclinical disruption of coagulation homeostasis and may improve prognostication, particularly for patients with severe systemic inflammation or shock. Machine learning (ML) algorithms may capture complex relationships between clinical variables better than linear regression (GLM ...
Brandi M. Macleod, Pamela A. Wilkins, Annette M. McCoy, Rebecca C. Bishop   +3 more
wiley   +1 more source

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors

Haemophilia, EarlyView.
Introduction Eptacog beta is an activated recombinant human factor VII bypassing agent approved for treating bleeding episodes (BEs) in patients aged ≥12 years with haemophilia A or B with inhibitors. Two initial dose regimens (IDRs) of either 75 or 225 µg/kg, followed by 75 µg/kg, are approved.
Manuel Carcao, Cédric Hermans, Adam Giermasz, Craig Kessler, Wolfgang Miesbach, Doris Quon, Jerzy Windyga, Johnny Mahlangu   +7 more
wiley   +1 more source

Risk Factors for Traumatic Lumbar Puncture in Children With ALL

Acta Paediatrica, EarlyView.
Sirkku Setänen, Arja Harila, Viola Metsistö, Christoffer Ehrstedt   +3 more
wiley   +1 more source

Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis

Haemophilia, EarlyView.
ABSTRACT Background Emicizumab is a bispecific monoclonal antibody mimicking factor (F) VIII activity and an effective therapy for prophylaxis in people with haemophilia A (PWHA). The FVIII‐equivalent activity (FVIIIeq) of emicizumab remains unknown. Objectives To estimate FVIIIeq of emicizumab using global assays of haemostasis.
Daniel Kraemmer, Cihan Ay, Judit Rejtő, Georg Heinze, Peter Quehenberger, Ingrid Pabinger, Oliver Königsbrügge   +6 more
wiley   +1 more source

Managing for change: October 15, 1990 v. 1, no. 5 [PDF]

, 1990
Bi-weekly newsletter of University Hospital's Change Project, provided to managers at the ...
Boston University Medical Center, Office of Publication Services
core  

Identifying Professional Responsibilities and Designing the Optimal Curriculum for Haemophilia Nurses in Spain: A Round Table Discussion

Haemophilia, EarlyView.
ABSTRACT Introduction There is a lack of consensus on professional competencies or educational requirements needed for registered nurses working with haemophilia patients (namely, haemophilia nurses) in thrombosis and haemostasis units in Spain. Their role is not officially recognised in many healthcare systems (HCS), including Spain.
Sara García‐Barcenilla, Montserrat Rambla Pérez, Noelia Pérez, Alfonso Castro Blanco, Anna Diaz, Carmen Fernandez Sarmiento, Eva Álvarez Martínez, María Dolores de Dios, María del Carmen García Martínez, María Teresa Torres, Mercè Triquell Garrell, Nuria Caballero Mencía, María Antonia Fernández   +12 more
wiley   +1 more source

Operation and performance of the Ciba-Corning 512 coagulation monitor during parabolic flight [PDF]

The goal was to assess the functionality and evaluate the procedures and operations required to operate the Ciba-Corning 512 Coagulation Monitor during parabolic flight. This monitor determines the clotting characteristics of blood. The analyzer operates
Gocke, Robyn, Greenthaner, Nancy K., Lloyd, Charles W.   +2 more
core   +1 more source